Reuters logo
BRIEF-Navidea Biopharmaceuticals says reaches settlement with CRG relating to loan agreement
February 23, 2017 / 3:33 PM / 7 months ago

BRIEF-Navidea Biopharmaceuticals says reaches settlement with CRG relating to loan agreement

Feb 23 (Reuters) - Navidea Biopharmaceuticals Inc :

* Navidea Biopharmaceuticals - On Feb 22, 2017, Co, CRG, and Cardinal Health 414 read into record a settlement in interpleader action pending in Ohio

* Navidea Biopharmaceuticals Inc - Parties agreed that CRG will be paid $59 million - SEC filing

* Navidea Biopharmaceuticals - Co, CRG agreed that the $2 million currently being held in escrow pursuant to court order in the Ohio case - SEC filing

* Navidea Biopharmaceuticals Inc - Cardinal Health 414 will post a $7 million letter of credit in favor of CRG

* Navidea Biopharmaceuticals - Co, CRG agreed $3 million currently being held in escrow pursuant to court order in Texas case to be released to co at closing of deal Source text : (bit.ly/2moYSpp) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below